Dhayendre L. Moodley

719 Umbilo Road
Durban, ZN 4051, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 110 publications

HIV acquisitions, safety, and pharmacokinetics of lenacapavir for HIV pre-exposure prophylaxis in pregnant and lactating women (PURPOSE 1): a substudy of a phase 3, randomised controlled trial.

HIV acquisitions, safety, and pharmacokinetics of lenacapavir for HIV pre-exposure prophylaxis in pregnant and lactating women (PURPOSE 1): a substudy of a phase 3, randomised controlled trial.

Journal: The lancet. HIV

Published: April 10, 2026

Associations of Plasma and Breast Milk HIV RNA and Tenofovir Concentrations with Risk of Postnatal HIV Transmission during Breastfeeding Among Women with and without ARV Exposure.

Associations of Plasma and Breast Milk HIV RNA and Tenofovir Concentrations with Risk of Postnatal HIV Transmission during Breastfeeding Among Women with and without ARV Exposure.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: March 16, 2026

High HBV Seroprotection Rates in Infants Born to People with HIV and HBV Infection in Sub-Saharan Africa.

High HBV Seroprotection Rates in Infants Born to People with HIV and HBV Infection in Sub-Saharan Africa.

Journal: Vaccine: X

Published: January 28, 2026

Metastatic Squamous Cell Carcinoma of the Cervix Presenting With Haematemesis and Duodenal Obstruction: A Case Report and Literature Review.

Metastatic Squamous Cell Carcinoma of the Cervix Presenting With Haematemesis and Duodenal Obstruction: A Case Report and Literature Review.

Journal: Case reports in gastrointestinal medicine

Published: January 08, 2026

Renal function in African women receiving tenofovir disoproxil fumarate as pre-exposure prophylaxis for HIV during pregnancy and postpartum: A postpartum safety analysis in the CAP016 randomized control trial.

Renal function in African women receiving tenofovir disoproxil fumarate as pre-exposure prophylaxis for HIV during pregnancy and postpartum: A postpartum safety analysis in the CAP016 randomized control trial.

Journal: HIV medicine

Published: January 05, 2026

Adherence to Oral HIV Pre-exposure Prophylaxis During Pregnancy and the Post-partum Period: Lessons Learned in an Open-Labelled Clinical Trial.

Adherence to Oral HIV Pre-exposure Prophylaxis During Pregnancy and the Post-partum Period: Lessons Learned in an Open-Labelled Clinical Trial.

Journal: AIDS and behavior

Published: October 24, 2025

Impact of STI and BV co-infection on genital cytokine profiles in postpartum women living with HIV on ART.

Impact of STI and BV co-infection on genital cytokine profiles in postpartum women living with HIV on ART.

Journal: Journal of reproductive immunology

Published: September 07, 2025

Inflammation, antiretroviral therapy continuation, and HIV disease progression in postpartum women with HIV.

Inflammation, antiretroviral therapy continuation, and HIV disease progression in postpartum women with HIV.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: June 06, 2025

Associations of Plasma and Breast Milk HIV RNA and Tenofovir Concentrations With Risk of Postnatal HIV Transmission During Breastfeeding Among Women With and Without ARV Exposure.

Associations of Plasma and Breast Milk HIV RNA and Tenofovir Concentrations With Risk of Postnatal HIV Transmission During Breastfeeding Among Women With and Without ARV Exposure.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: June 05, 2025

Genital tract infections, antiretroviral treatment and HIV-1 viral load in early postpartum women: : implications for sexual and breastfeeding HIV transmission.

Genital tract infections, antiretroviral treatment and HIV-1 viral load in early postpartum women: : implications for sexual and breastfeeding HIV transmission.

Journal: BMC infectious diseases

Published: May 14, 2025

Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-MTM adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial.

Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-MTM adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial.

Journal: Human vaccines & immunotherapeutics

Published: December 12, 2024

Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.

Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.

Journal: The New England journal of medicine

Published: July 24, 2024

Showing 1-12 of 110

Last Updated: 09/26/2026